Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

NCT03453528 is registered in ClinicalTrials.gov with Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS as lead sponsor.

NCT NCT03453528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03453528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors
Lead sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase
Not applicable
Overall status
Completed
Start date
July 4, 2017
Completion date
January 3, 2025
Enrollment
1,225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mcrpc or advanced/metastatic solid tumors, prostate-specific membrane antigen